2459-10-1COC(=O)c1ccc(C(=O)OC)c(C(=O)OC)c1MJHNUUNSCNRGJE-UHFFFAOYSA-N2459-10-1FCS -> FDA Cumulative Estimated Daily Intake (CEDI)
FCS -> FDA Inventory of Food Contact Substances Listed in 21 CFR
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
H411 (100%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]
P273, P391, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 109 reports by companies from 1 notifications to the ECHA C&L Inventory.
Chemical: 1,2,4-Benzenetricarboxylic acid, trimethyl ester
Regulation (EC) No 1935/2004 (amended)
Status: Active Update: 15-02-2019 https://echa.europa.eu/registration-dossier/-/registered-dossier/27667
SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.
(1979) No Data
(1981) No Data
(1979) No Data
(1981) No Data
(1979) No Data
(1981) PROBABLY GREATER THAN 2.27X10+6 GRAMS
1,2,4-Benzenetricarboxylic acid, 1,2,4-trimethyl ester: ACTIVE
ADDITION OF TRIMELLITIC ACID ESTERS, INCLUDING TRIMETHYL 1,2,4-BENZENETRICARBOXYLATE, MARKEDLY DECREASED DRIFT OF AGROCHEMICAL POWDER & IMPROVED FLUIDITY & ADHESIVENESS ON PLANTS.
PLASTICIZER (POSSIBLE USE)
VerwendenTrimethyl 1,2,4-benzenetricarboxylate has been used in the synthesis of polymers which can be cleaved at predetermined sites by ionizing radiations.
Wird geladen…
DTXSID8044620CHEMBL3183850Trimethyl 1,2,4-benzenetricarboxylate (CAS# 2459-10-1) was evaluated for acute oral toxicity. The test substance was administered by intragastric intubation to young adult ChR-CD male rats. Dosage levels and mortality data are as follows: 10,000 (0/10); 11,000 (4/10); 12,000 (4/10); and 14,000 mg/kg of body weight (8/10), with all deaths occurring 4-days after dosing. Clinical signs at 10,000 mg/kg and above included salivation, weakness, stained and wet perineal area, stained face, pallor, chromodacryorrhea, and moderate weight loss. The LD50 was determined to be 12,232 mg/kg b.w.